Detalles de la búsqueda
1.
Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes.
BMC Cancer
; 23(1): 869, 2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715134
2.
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Breast Cancer Res Treat
; 196(3): 613-622, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207619
3.
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line Chemotherapy.
Oncologist
; 26(5): e742-e748, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245164
4.
Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study.
Oncologist
; 25(9): e1286-e1291, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32058619
5.
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Mol Cancer
; 18(1): 7, 2019 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626401
6.
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
BMC Cancer
; 18(1): 331, 2018 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29587760
7.
Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.
Breast Cancer Res Treat
; 160(2): 197-209, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27663434
8.
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.
Cancer Res Treat
; 56(2): 513-521, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846468
9.
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.
NPJ Breast Cancer
; 10(1): 45, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871705
10.
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors.
J Pers Med
; 13(2)2023 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36836599
11.
The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.
Ann Med
; 55(1): 2232299, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431586
12.
Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis.
Cancer Med
; 2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151972
13.
Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer.
Gland Surg
; 12(2): 225-242, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915811
14.
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
Cancer Med
; 12(12): 13019-13030, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096751
15.
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.
J Oncol
; 2022: 7839041, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36245976
16.
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Ann Med
; 53(1): 1358-1369, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396843
17.
Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer.
Front Oncol
; 11: 747012, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858823
18.
Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy.
Transl Cancer Res
; 9(2): 1225-1234, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117467
19.
EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients.
Transl Lung Cancer Res
; 9(3): 471-483, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676311
20.
Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer.
PeerJ
; 8: e10468, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33335811